# Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection

> **NCT00000587** · PHASE2 · COMPLETED · sponsor: **Thomas Jefferson University**

## Conditions studied

- Acquired Immunodeficiency Syndrome
- Anemia
- Hematologic Diseases
- HIV Infections
- Blood Disease

## Interventions

- **PROCEDURE:** erythropoietin, recombinant

## Key facts

- **NCT ID:** NCT00000587
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1988-09
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** — (—)
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000587, "Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*